Nath Bio-Genes (India) Limited Share Price

Equities

NATHBIOGEN

INE448G01010

Fishing & Farming

Market Closed - NSE India S.E. 05:13:52 15/05/2024 pm IST 5-day change 1st Jan Change
188.4 INR +1.10% Intraday chart for Nath Bio-Genes (India) Limited -5.89% -9.16%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2022 2.78B 33.38M Sales 2023 3.01B 36.14M Capitalization 2.68B 32.19M
Net income 2022 -673M -8.07M Net income 2023 350M 4.2M EV / Sales 2022 1.78 x
Net Debt 2022 888M 10.65M Net Debt 2023 672M 8.06M EV / Sales 2023 1.11 x
P/E ratio 2022
-6.02 x
P/E ratio 2023
7.67 x
Employees 433
Yield 2022
0.94%
Yield 2023
1.42%
Free-Float 38.47%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Nath Bio-Genes Limited, Q4 2024 Earnings Call, May 09, 2024
Nath Bio-Genes Limited Recommends Dividend for Financial Year 2023-24 CI
Nath Bio-Genes Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Nath Bio-Genes Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Nath Bio-Genes Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Transcript : Nath Bio-Genes Limited, Q2 2024 Earnings Call, Oct 17, 2023
Nath Bio-Genes Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Nath Bio-Genes Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Nath Bio-Genes Limited Approves Final Dividend for Financial Year Ended 31St March 2023 CI
Transcript : Nath Bio-Genes Limited, Q4 2023 Earnings Call, Apr 24, 2023
Nath Bio-Genes Limited Recommends Dividend for Financial Year 2022-23 CI
Nath Bio-Genes Limited Announces Resignation of Sweta Akash Kagliwal as Director CI
Nath Bio-Genes Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Nath Bio-Genes Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Nath Bio-Genes Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
More news

Latest transcript on Nath Bio-Genes (India) Limited

1 day+1.10%
1 week-5.89%
Current month-8.68%
1 month-3.73%
3 months-11.72%
6 months-4.73%
Current year-9.16%
More quotes
1 week
184.05
Extreme 184.05
204.60
1 month
184.05
Extreme 184.05
214.50
Current year
173.10
Extreme 173.1
238.90
1 year
159.00
Extreme 159
244.60
3 years
128.85
Extreme 128.85
473.95
5 years
127.30
Extreme 127.3
473.95
10 years
59.00
Extreme 59
585.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 30/99/30
Director of Finance/CFO 63 -
Compliance Officer 30 31/18/31
Members of the board TitleAgeSince
Chief Executive Officer 64 30/99/30
Director/Board Member 60 10/12/10
Director/Board Member 42 30/15/30
More insiders
Date Price Change Volume
15/24/15 188.4 +1.10% 41,141
14/24/14 186.4 +0.24% 48,848
13/24/13 185.9 -1.93% 37,601
10/24/10 189.6 -2.07% 62,212
09/24/09 193.6 -5.29% 73,531

Delayed Quote NSE India S.E., May 15, 2024 at 05:13 pm IST

More quotes
Nath Bio-Genes (India) Limited is an India-based formidable seed company, which is focused on developing and supplying BT, hybrid and varietal seeds to farmers. The Company is engaged in the Seed Cultivation segment. The Company’s products categories include oilseeds and fiber, field crops, vegetables and plant nutrition. Its fiber and oils seeds include cotton and mustard. The Company's vegetable crop range includes chili, okra, tomato, bottle gourd, bitter gourd, cucumber, coriander, pumpkin, tinda and others. Its field corps include corn, jowar, hybrid paddy, research paddy and wheat. Its plant nutrition products include WINPro GOLii, WINall and Win Chin Win. Its forage products include NUTRIMAX and NUTRIMAX GOLD. The Company has seed processing facilities processing plants located in Maharashtra, Telangana and Andhra Pradesh. The Company also has processing arrangements in Gujarat, Karnataka, Tamil Nadu, Madhya Pradesh and Rajasthan on custom basis.
More about the company
  1. Stock Market
  2. Equities
  3. NATHBIOGEN Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW